Agency Generic Information Collection Request; 30-Day Public Comment Request, 58285-58286 [2021-22946]
Download as PDF
<![CDATA[
58285
Federal Register / Vol. 86, No. 201 / Thursday, October 21, 2021 / Notices
who are appointed as members of the
Council.
Dated: October 5, 2021.
Caroline Talev,
Management Analyst, Office of Infectious
Disease and HIV/AIDS Policy, Alternate
Designated Federal Officer, Presidential
Advisory Council on HIV/AIDS, Office of the
Assistant Secretary for Health, Department
of Health and Human Services.
[FR Doc. 2021–22950 Filed 10–20–21; 8:45 am]
BILLING CODE 4150–43–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier OS–0955–New]
Agency Generic Information Collection
Request; 30-Day Public Comment
Request
Office of the Secretary, Health
and Human Service, HHS.
ACTION: Notice.
AGENCY:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before November 22,
2021.
SUMMARY:
Submit your comments to
OIRA_submission@omb.eop.gov or via
facsimile to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT:
Sherrette Funn, Sherrette.Funn@hhs.gov
or (202) 795–7714. When requesting
information, please include the
ADDRESSES:
recognition that by capturing and
accessing SDOH data during the course
of care, providers can more easily
address non-clinical factors, such as
food, housing, and transportation
insecurities, which can have a profound
impact on a person’s overall health.
The 21st Century Cures Act (Cures
Act) requires HHS and ONC to improve
the interoperability of health
information. ONC’s Cures Act final rule
identifies important data elements that
should be made electronically available
and exchanged through the use of health
information technology (IT).
In support of these efforts, ONC seeks
to better understand patients’ and health
care providers’ knowledge of SDOH,
how SDOH data are currently
documented in the electronic health
record and how this information is used
in patient care. Additionally, ONC seeks
to understand challenges experienced
and preferences for SDOH data
collection, sharing and utilization from
both the provider and patient
perspectives.
A series of 20 focus groups, a mix of
asynchronous (discussion board) and
synchronous (live), will be conducted
among groups of healthcare
professionals (10 groups) and patients/
care partners (10 groups), representing
various backgrounds, demographics,
and healthcare professions, to learn
more about their experiences and
thoughts relating to the capture and
utilization of SDOH data. A
prescreening questionnaire will be sent
to 1,500 individuals and 200 of those
1,500 people will be chosen to
participate in the focus groups. Each
individual will participate in one 90minute focus group.
document identifier 0955–New–30D
and project title for reference.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Access,
Exchange and Use of Social
Determinants of Health Data in Clinical
Notes.
Type of Collection: New.
OMB No.: 0955–NEW—Office of the
National Coordinator for Health
Information Technology.
Abstract: The Department of Health
and Human Services (HHS), Office of
the Secretary, Office of the National
Coordinator for Health Information
Technology (ONC), promotes the access,
exchange, and use of electronic health
information to improve health care.
There are ongoing efforts to determine
what types of information should be
recorded in patients’ electronic medical
records and how that information can be
utilized to improve health and
healthcare. Data reflecting Social
Determinants of Health (SDOH)—the
conditions in which people live, learn,
work, and play—is limited across
healthcare yet is vital to collect and
understand for both individual care and
public health. There is a growing
ESTIMATED ANNUALIZED BURDEN TABLE
jspears on DSK121TN23PROD with NOTICES1
Average
burden per
response
(in hours)
Type of
respondent
Prescreening
Questionnaire
(English).
Prescreening Questionnaire (Spanish).
Prescreening Questionnaire .............
Patients and Care Partners .............
675
1
5/60
56
Patient and Care Partners (Spanish
speakers).
Clinicians and Healthcare Professionals.
Patients and Care Partners .............
Patients and Care Partners .............
Patients and Care Partners (Spanish speakers).
Clinicians and Healthcare Professionals.
Clinicians and Healthcare Professionals.
75
1
5/60
6
750
1
5/60
63
10
80
10
1
1
1
90/60
90/60
90/60
15
120
15
90
1
90/60
135
10
1
90/60
15
1700
1
........................
425
Asynchronous Focus Group .............
Synchronous Focus Group (English)
Synchronous Focus Group (Spanish)
Asynchronous Focus Group .............
Synchronous Focus Group ...............
Total ...........................................
VerDate Sep<11>2014
17:35 Oct 20, 2021
Number of
respondents
Number
responses per
respondent
Form name
...........................................................
Jkt 256001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
E:\FR\FM\21OCN1.SGM
21OCN1
Total burden
hours
58286
Federal Register / Vol. 86, No. 201 / Thursday, October 21, 2021 / Notices
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2021–22946 Filed 10–20–21; 8:45 am]
BILLING CODE 4150–45–P
Dated: October 15, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–22956 Filed 10–20–21; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
National Institute on Drug Abuse;
Notice of Closed Meetings
jspears on DSK121TN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDAL Conflicts SEP.
Date: November 29, 2021.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Gerald L. McLaughlin,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda,
MD 20892, (301) 827–5819, gm145a@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; HEAL
Initiative: America’s Startups and Small
Businesses Build Technologies to Stop the
Opioid Crisis (R41/R42/R43/R44—Clinical
Trial Optional).
Date: December 14–15, 2021.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Gerald L. McLaughlin,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, National
Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda,
MD 20892, (301) 827–5819, gm145a@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
VerDate Sep<11>2014
17:35 Oct 20, 2021
Jkt 256001
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Prokaryotic Cell and
Molecular Biology Study Section,
November 3, 2021, 10:00 a.m. to
November 4, 2021, 7:00 p.m., National
Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD, 20892
which was published in the Federal
Register on October 4, 2021, FRN Doc
#2021–21459, V–86—Page 54703.
This notice is being amended to
change the meeting date from November
3–4, 2021 to November 3, 2021. The
meeting time and place remains the
same. The meeting is closed to the
public.
Dated: October 18, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–22965 Filed 10–20–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Biological Chemistry, Biophysics
and Assay Development.
Date: November 18–19, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John Harold Laity, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–8254, john.laity@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR20–103:
Collaborative Program Grant for
Multidisciplinary Teams (RM1).
Date: November 22, 2021.
Time: 11:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David R. Jollie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4150,
MSC 7806, Bethesda, MD 20892, (301)–435–
1722, jollieda@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Tumor Progression, Metastasis, and
Microenvironment.
Date: November 22, 2021.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Manzoor Zarger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6208,
MSC 7804, Bethesda, MD 20892, (301) 435–
2477, zargerma@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 15, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–22955 Filed 10–20–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\21OCN1.SGM
21OCN1
]]>Agencies
[Federal Register Volume 86, Number 201 (Thursday, October 21, 2021)]
[Notices]
[Pages 58285-58286]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-22946]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier OS-0955-New]
Agency Generic Information Collection Request; 30-Day Public
Comment Request
AGENCY: Office of the Secretary, Health and Human Service, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be received on or before November 22,
2021.
ADDRESSES: Submit your comments to [email protected] or via
facsimile to (202) 395-5806.
FOR FURTHER INFORMATION CONTACT: Sherrette Funn, [email protected]
or (202) 795-7714. When requesting information, please include the
document identifier 0955-New-30D and project title for reference.
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collection: Access, Exchange and Use of Social
Determinants of Health Data in Clinical Notes.
Type of Collection: New.
OMB No.: 0955-NEW--Office of the National Coordinator for Health
Information Technology.
Abstract: The Department of Health and Human Services (HHS), Office
of the Secretary, Office of the National Coordinator for Health
Information Technology (ONC), promotes the access, exchange, and use of
electronic health information to improve health care. There are ongoing
efforts to determine what types of information should be recorded in
patients' electronic medical records and how that information can be
utilized to improve health and healthcare. Data reflecting Social
Determinants of Health (SDOH)--the conditions in which people live,
learn, work, and play--is limited across healthcare yet is vital to
collect and understand for both individual care and public health.
There is a growing recognition that by capturing and accessing SDOH
data during the course of care, providers can more easily address non-
clinical factors, such as food, housing, and transportation
insecurities, which can have a profound impact on a person's overall
health.
The 21st Century Cures Act (Cures Act) requires HHS and ONC to
improve the interoperability of health information. ONC's Cures Act
final rule identifies important data elements that should be made
electronically available and exchanged through the use of health
information technology (IT).
In support of these efforts, ONC seeks to better understand
patients' and health care providers' knowledge of SDOH, how SDOH data
are currently documented in the electronic health record and how this
information is used in patient care. Additionally, ONC seeks to
understand challenges experienced and preferences for SDOH data
collection, sharing and utilization from both the provider and patient
perspectives.
A series of 20 focus groups, a mix of asynchronous (discussion
board) and synchronous (live), will be conducted among groups of
healthcare professionals (10 groups) and patients/care partners (10
groups), representing various backgrounds, demographics, and healthcare
professions, to learn more about their experiences and thoughts
relating to the capture and utilization of SDOH data. A prescreening
questionnaire will be sent to 1,500 individuals and 200 of those 1,500
people will be chosen to participate in the focus groups. Each
individual will participate in one 90-minute focus group.
Estimated Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Average
Type of Number of Number burden per Total burden
Form name respondent respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Prescreening Questionnaire Patients and 675 1 5/60 56
(English). Care Partners.
Prescreening Questionnaire Patient and Care 75 1 5/60 6
(Spanish). Partners
(Spanish
speakers).
Prescreening Questionnaire.... Clinicians and 750 1 5/60 63
Healthcare
Professionals.
Asynchronous Focus Group...... Patients and 10 1 90/60 15
Care Partners.
Synchronous Focus Group Patients and 80 1 90/60 120
(English). Care Partners.
Synchronous Focus Group Patients and 10 1 90/60 15
(Spanish). Care Partners
(Spanish
speakers).
Asynchronous Focus Group...... Clinicians and 90 1 90/60 135
Healthcare
Professionals.
Synchronous Focus Group....... Clinicians and 10 1 90/60 15
Healthcare
Professionals.
---------------------------------------------------------------
Total..................... ................ 1700 1 .............. 425
----------------------------------------------------------------------------------------------------------------
[[Page 58286]]
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance Officer, Office of the
Secretary.
[FR Doc. 2021-22946 Filed 10-20-21; 8:45 am]
BILLING CODE 4150-45-P
